Decrease in BCR-ABL is accompanied by an impressive increase in mRNA of CCN3 and the negative regulation of CCN3 observed in CML may be mediated by the expression of miR-130a/b.35,36. The gene discussed is CCN3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.